Yahoo
    HKSE - Delayed Quote HKD

    WuXi XDC Cayman Inc. (2268.HK)

    65.950 -0.700 (-1.05%)
    As of 1:41:52 PM GMT+8. Market Open.
    Loading Chart for 2268.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    WuXi XDC Cayman (SEHK:2268) Stock May Be 32% Undervalued Despite ADC Awards

    WuXi XDC Cayman (SEHK:2268) Stock May Be 32% Undervalued Despite ADC Awards
    Simply Wall St. 7d ago
    WuXi XDC Named the Winner of

    WuXi XDC Named the Winner of "Best CDMO" for the Fourth Consecutive Year and the Winner of "Best CRO" for the Second Consecutive Year
    PR Newswire 17d ago
    WuXi XDC Cayman (SEHK:2268) Secures GMP Release At New Singapore Site

    WuXi XDC Cayman (SEHK:2268) Secures GMP Release At New Singapore Site
    Simply Wall St. 1mo ago
    WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion

    WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion
    PR Newswire 1mo ago
    Ona Therapeutics to develop ADC with WuXi’s payload-linker platform

    Ona Therapeutics to develop ADC with WuXi’s payload-linker platform
    Pharmaceutical Technology 1mo ago
    WuXi XDC Cayman Inc (STU:L74) (H1 2026) Earnings Call Highlights: Record Backlog and First $1B ...

    WuXi XDC Cayman Inc (STU:L74) (H1 2026) Earnings Call Highlights: Record Backlog and First $1B ...
    GuruFocus.com 2mo ago
    WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership

    WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership
    PR Newswire 2mo ago
    Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day

    Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day
    PR Newswire 4mo ago
    Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC

    Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC
    GlobeNewswire 6mo ago
    WuXi XDC Cayman Inc (FRA:L74) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ...

    WuXi XDC Cayman Inc (FRA:L74) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ...
    GuruFocus.com 7mo ago
    Asian Equity Gems Estimated Below Fair Value In January 2026

    Asian Equity Gems Estimated Below Fair Value In January 2026
    Simply Wall St. 9mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: